MacroGenics Stock Price (NASDAQ:MGNX)

Add to My Stocks
$17.33 $0.28 (1.64%) MGNX stock closing price Sep 25, 2017 (Closing)
Prev Close* : $17.05
Market Cap:
Day Low: $16.66
52 Week Low: $14.36
Open: $16.96
Volume: 254577
Day High: $17.35
52 Week High: $32.68

Latest Stock Market News

Latest Articles

MacroGenics News - From Partners

MGNX Stockcharts

View MGNX PE ratio, PS ratio stocks charts and compare with peers.
MGNX Chart
Note: Compare MacroGenics stock price history with the index and industry peers.

MacroGenics Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

MacroGenics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

MGNX Industry Peers

Company Price Change (%)
Atricure (ATRC)21.970.02 (0.09%)
Lantheus Holdings (LNTH)17.50.15 (0.86%)
Merck (MRK)65.180.05 (0.08%)
Johnson & Johnson (JNJ)131.170.22 (0.17%)
Pfizer (PFE)35.510.45 (1.25%)
Gilead Sciences (GILD)83.610.34 (0.41%)
Xencor (XNCR)22.470.62 (2.84%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
VERU INC (VERU)2.320.15 (6.91%)
Rockwell Medical (RMTI)7.610.23 (3.12%)
Cerus (CERS)2.680.08 (3.08%)
OraSure (OSUR)22.140.4 (1.84%)
Omeros (OMER)21.260.38 (1.82%)
MacroGenics (MGNX)17.330.28 (1.64%)
NuVasive (NUVA)55.060.81 (1.49%)
Top gainers from Medical Products industry
* As of Sep 26, 2017
CompanyPriceChange (%)
Fonar (FONR)28.80.9 (3.03%)
ICU Medical (ICUI)181.353.55 (1.92%)
Medtronic (MDT)78.271.43 (1.79%)
Bio-Rad Laboratories (BIO)225.373.31 (1.45%)
Trinity Biotech (TRIB)5.480.08 (1.44%)
Enzymotec (ENZY)11.150.15 (1.33%)
Baxter International (BAX)62.760.75 (1.18%)
Top losers from Medical Products industry
* As of Sep 26, 2017

MacroGenics Inc Stock News - Partner Headlines

MacroGenics Financial Statements

income statement20162015201420132012
Net Sales or Revenues91.88M100.85M47.79M58.03M63.82M
Net Income-58.52M-20.14M-38.31M-0.26M8.36M
Total Operating Expense151.92M121.03M86.1M57.66M55.61M
View MacroGenics income statement
balance sheet20162015201420132012
Total Assets311.26M359.26M173.88M125.78M53.74M
Total Liabilities42.51M45.93M52.6M46.86M61.98M
Shareholders Equity268.75M313.33M121.28M78.91M-8.23M
View MacroGenics balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-4.92M-4.23M0.48M-16.59M-16.59M
Net Cash from (used by) Operating Activities-43.67M-13.66M-32.75M-14.17M-6.58M
Increase (Decrease) in Prop Plant And Equipment-11.38M-9.19M-3.57M-2.96M-0.94M
View MacroGenics cash flow statement

MacroGenics Stock Message Board

As of last trading day, MacroGenics stock price was 17.33. MacroGenics market capitalization is 627.41M and it represents the total market value of MGNX stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing MacroGenics stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that MacroGenics is worth a lot, it will most likely be reflected in an inflated MacroGenics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 254577 on the last trading day, as is evident from MacroGenics stock chart, and MGNX stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. MacroGenics stock price history, gives the entire historical data for MGNX stock.